Skip to main content

Table 2 Distribution of projected 5-year risk (%, UKPDS risk engine) of coronary and other vascular outcomes for randomized patients with no history of cardiovascular disease (n = 7664)

From: Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

Outcome measures

Projected 5-year risk (%, from the UKPDS risk engine)

<5%

5%–<10%

10%–<15%

15%–<20%

≥20%

All CHD

24.6

37.0

20.7

9.5

8.2

Fatal CHD

56.1

26.8

9.9

4.6

2.6

All stroke

79.3

17.0

2.8

0.7

0.2

Fatal stroke

99.9

0.1

0.0

0.0

0.0